173 related articles for article (PubMed ID: 31138566)
1. Efficacy of a Multimechanistic Monoclonal Antibody Combination against Staphylococcus aureus Surgical Site Infections in Mice.
Ortines RV; Wang Y; Liu H; Dikeman DA; Pinsker BL; Miller RJ; Kim SE; Ackerman NE; Rizkallah JF; Marcello LT; Cohen TS; Tkaczyk C; Sellman BR; Miller LS
Antimicrob Agents Chemother; 2019 Aug; 63(8):. PubMed ID: 31138566
[TBL] [Abstract][Full Text] [Related]
2. Multimechanistic Monoclonal Antibodies (MAbs) Targeting Staphylococcus aureus Alpha-Toxin and Clumping Factor A: Activity and Efficacy Comparisons of a MAb Combination and an Engineered Bispecific Antibody Approach.
Tkaczyk C; Kasturirangan S; Minola A; Jones-Nelson O; Gunter V; Shi YY; Rosenthal K; Aleti V; Semenova E; Warrener P; Tabor D; Stover CK; Corti D; Rainey G; Sellman BR
Antimicrob Agents Chemother; 2017 Aug; 61(8):. PubMed ID: 28584141
[TBL] [Abstract][Full Text] [Related]
3. Improved Protection in a Rabbit Model of Community-Associated Methicillin-Resistant Staphylococcus aureus Necrotizing Pneumonia upon Neutralization of Leukocidins in Addition to Alpha-Hemolysin.
Diep BA; Le VT; Visram ZC; Rouha H; Stulik L; Dip EC; Nagy G; Nagy E
Antimicrob Agents Chemother; 2016 Oct; 60(10):6333-40. PubMed ID: 27527081
[TBL] [Abstract][Full Text] [Related]
4. Targeting Alpha Toxin and ClfA with a Multimechanistic Monoclonal-Antibody-Based Approach for Prophylaxis of Serious Staphylococcus aureus Disease.
Tkaczyk C; Hamilton MM; Sadowska A; Shi Y; Chang CS; Chowdhury P; Buonapane R; Xiao X; Warrener P; Mediavilla J; Kreiswirth B; Suzich J; Stover CK; Sellman BR
mBio; 2016 Jun; 7(3):. PubMed ID: 27353753
[TBL] [Abstract][Full Text] [Related]
5. Five birds, one stone: neutralization of α-hemolysin and 4 bi-component leukocidins of Staphylococcus aureus with a single human monoclonal antibody.
Rouha H; Badarau A; Visram ZC; Battles MB; Prinz B; Magyarics Z; Nagy G; Mirkina I; Stulik L; Zerbs M; Jägerhofer M; Maierhofer B; Teubenbacher A; Dolezilkova I; Gross K; Banerjee S; Zauner G; Malafa S; Zmajkovic J; Maier S; Mabry R; Krauland E; Wittrup KD; Gerngross TU; Nagy E
MAbs; 2015; 7(1):243-54. PubMed ID: 25523282
[TBL] [Abstract][Full Text] [Related]
6. Multimechanistic Monoclonal Antibody Combination Targeting Key Staphylococcus aureus Virulence Determinants in a Rabbit Model of Prosthetic Joint Infection.
Mao Y; Valour F; Nguyen NTQ; Doan TMN; Koelkebeck H; Richardson C; Cheng LI; Sellman BR; Tkaczyk C; Diep BA
Antimicrob Agents Chemother; 2021 Jun; 65(7):e0183220. PubMed ID: 33903108
[TBL] [Abstract][Full Text] [Related]
7. Antigenic landscapes on
Kailasan S; Kant R; Noonan-Shueh M; Kanipakala T; Liao G; Shulenin S; Leung DW; Alm RA; Adhikari RP; Amarasinghe GK; Gross ML; Aman MJ
MAbs; 2022; 14(1):2083467. PubMed ID: 35730685
[No Abstract] [Full Text] [Related]
8. Novel human monoclonal antibodies targeting the F subunit of leukocidins reduce disease progression and mortality caused by Staphylococcus aureus.
Jing C; Liu C; Liu F; Gao Y; Liu Y; Guan Z; Xuan B; Yu Y; Yang G
BMC Microbiol; 2018 Nov; 18(1):181. PubMed ID: 30419818
[TBL] [Abstract][Full Text] [Related]
9. Protective activity of anti-lipoteichoic acid monoclonal antibody in single or combination therapies in methicillin-resistant Staphylococcus aureus-induced murine sepsis models.
Ohsawa H; Baba T; Enami J; Hiramatsu K
J Infect Chemother; 2020 May; 26(5):520-522. PubMed ID: 32001173
[TBL] [Abstract][Full Text] [Related]
10. High prevalence of methicillin resistant staphylococci strains isolated from surgical site infections in Kinshasa.
Iyamba JM; Wambale JM; Lukukula CM; za Balega Takaisi-Kikuni N
Pan Afr Med J; 2014; 18():322. PubMed ID: 25478043
[TBL] [Abstract][Full Text] [Related]
11. Monoclonal antibodies neutralizing alpha-hemolysin, bicomponent leukocidins, and clumping factor A protected against
Nguyen NTQ; Doan TNM; Sato K; Tkaczyk C; Sellman BR; Diep BA
Front Immunol; 2023; 14():1260627. PubMed ID: 37781371
[TBL] [Abstract][Full Text] [Related]
12. Proportions of Staphylococcus aureus and methicillin-resistant Staphylococcus aureus in patients with surgical site infections in mainland China: a systematic review and meta-analysis.
Yang Z; Wang J; Wang W; Zhang Y; Han L; Zhang Y; Nie X; Zhan S
PLoS One; 2015; 10(1):e0116079. PubMed ID: 25602284
[TBL] [Abstract][Full Text] [Related]
13. Monoclonal antibody anti-PBP2a protects mice against MRSA (methicillin-resistant Staphylococcus aureus) infections.
Saraiva FB; de Araújo ACC; de Araújo AÉV; Senna JPM
PLoS One; 2019; 14(11):e0225752. PubMed ID: 31774881
[TBL] [Abstract][Full Text] [Related]
14. Preclinical Efficacy of Clumping Factor A in Prevention of Staphylococcus aureus Infection.
Li X; Wang X; Thompson CD; Park S; Park WB; Lee JC
mBio; 2016 Feb; 7(1):e02232-15. PubMed ID: 26838725
[TBL] [Abstract][Full Text] [Related]
15. Disarming Staphylococcus aureus from destroying human cells by simultaneously neutralizing six cytotoxins with two human monoclonal antibodies.
Rouha H; Weber S; Janesch P; Maierhofer B; Gross K; Dolezilkova I; Mirkina I; Visram ZC; Malafa S; Stulik L; Badarau A; Nagy E
Virulence; 2018 Jan; 9(1):231-247. PubMed ID: 29099326
[TBL] [Abstract][Full Text] [Related]
16. Monoclonal Antibody Targeting Staphylococcus aureus Surface Protein A (SasA) Protect Against Staphylococcus aureus Sepsis and Peritonitis in Mice.
Yang Y; Qian M; Yi S; Liu S; Li B; Yu R; Guo Q; Zhang X; Yu C; Li J; Xu J; Chen W
PLoS One; 2016; 11(2):e0149460. PubMed ID: 26926145
[TBL] [Abstract][Full Text] [Related]
17. Molecular characteristics of community-acquired methicillin-resistant Staphylococcus aureus in Hokkaido, northern main island of Japan: identification of sequence types 6 and 59 Panton-Valentine leucocidin-positive community-acquired methicillin-resistant Staphylococcus aureus.
Kawaguchiya M; Urushibara N; Kuwahara O; Ito M; Mise K; Kobayashi N
Microb Drug Resist; 2011 Jun; 17(2):241-50. PubMed ID: 21395449
[TBL] [Abstract][Full Text] [Related]
18. Protective Efficacy of Monoclonal Antibodies Neutralizing Alpha-Hemolysin and Bicomponent Leukocidins in a Rabbit Model of Staphylococcus aureus Necrotizing Pneumonia.
Vu TTT; Nguyen NTQ; Tran VG; Gras E; Mao Y; Jung DH; Tkaczyk C; Sellman BR; Diep BA
Antimicrob Agents Chemother; 2020 Feb; 64(3):. PubMed ID: 31844012
[No Abstract] [Full Text] [Related]
19. Survival during influenza-associated bacterial superinfection improves following viral- and bacterial-specific monoclonal antibody treatment.
Robinson KM; Ramanan K; Tobin JM; Nickolich KL; Pilewski MJ; Kallewaard NL; Sellman BR; Cohen TS; Alcorn JF
JCI Insight; 2019 Jul; 4(14):. PubMed ID: 31341107
[TBL] [Abstract][Full Text] [Related]
20. Anti-alpha-toxin monoclonal antibody and antibiotic combination therapy improves disease outcome and accelerates healing in a Staphylococcus aureus dermonecrosis model.
Hilliard JJ; Datta V; Tkaczyk C; Hamilton M; Sadowska A; Jones-Nelson O; O'Day T; Weiss WJ; Szarka S; Nguyen V; Prokai L; Suzich J; Stover CK; Sellman BR
Antimicrob Agents Chemother; 2015 Jan; 59(1):299-309. PubMed ID: 25348518
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
